Reduced Muscarinic Type 2 Receptor Binding in Subjects With Bipolar Disorder | Zendy

Dara M. Can | Zendy; Richard E. Carson | Zendy; Allison C. Nugent | Zendy; William C. Eckelman | Zendy; Dale O. Kiesewetter | Zendy; Joan P. Williams | Zendy; Denise Rollis | Zendy; Michele Drevets | Zendy; Shilpa K Gandhi | Zendy; Gerardo Solorio | Zendy; Wayne C. Drevets | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Reduced Muscarinic Type 2 Receptor Binding in Subjects With Bipolar Disorder

Author(s) -

Dara M. Can,

Richard E. Carson,

Allison C. Nugent,

William C. Eckelman,

Dale O. Kiesewetter,

Joan P. Williams,

Denise Rollis,

Michele Drevets,

Shilpa K Gandhi,

Gerardo Solorio,

Wayne C. Drevets

Publication year - 2006

Publication title -

archives of general psychiatry

Language(s) - English

Resource type - Journals

eISSN - 1538-3636

pISSN - 0003-990X

DOI - 10.1001/archpsyc.63.7.741

Subject(s) - bipolar disorder , psychology , medicine , major depressive disorder , bipolar ii disorder , depression (economics) , endocrinology , psychiatry , amygdala , mood , economics , macroeconomics

A variety of indirect evidence has implicated the central muscarinic-cholinergic system, and more specifically the type 2 muscarinic (M2) receptor, in the pathogenesis of depressive symptoms arising in major depressive disorder and bipolar disorder.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research